CD40 Ligand antibody (FITC)

Catalog No. ABIN206215

This Hamster Monoclonal antibody specifically detects CD40 Ligand in FACS and IP. It exhibits reactivity toward Mouse.

Quick Overview for CD40 Ligand antibody (FITC) (ABIN206215)

Target: CD40 Ligand (CD40LG)

Reactivity: Mouse

Host: Hamster

Clonality: Monoclonal

Conjugate: This CD40 Ligand antibody is conjugated to FITC

Application: Flow Cytometry (FACS), Immunoprecipitation (IP)

Product Details anti-CD40 Ligand Antibody (FITC)

Specificity: Recognizes the murine CD40 ligand, also known as CD40L or CD154. CD154 is a ~39 kD cell surface glycoprotein. CD154 is expressed by activated CD4+ve T lymphocytes. Is routinely tested in flow cytometry on mouse CD40L transfected L cells.

Purification: Protein G purified

Immunogen: L cells transfected with CD40L.

Type of Immunogen: Cells

Isotype: IgG

Application Details

Application Notes: Approved: Flo (1:1), IP

Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. Flow Cytometry: Use 10 μL of the suggested working dilution to label 10^6 cells in 100 μL. The Fc region of monoclonal antibodies may bind non-specifically to cells expressing low affinity Fc receptors.

Comment:

Target Species of Antibody: Mouse

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: Lot specific

Buffer: PBS, 0.09 % sodium azide, 1 % BSA.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Target Details for CD40 Ligand

Target: CD40 Ligand (CD40LG)

Alternative Name: CD40LG / CD40L / CD154

Background: Name/Gene ID: CD40LG
Family: TNF

Synonyms: CD40LG, CD154, CD154 antigen, CD40-L, CD40 ligand, CD40L, gp39, HIGM1, IGM, IMD3, T-BAM, TNFSF5, CD40 antigen ligand, CD54, HCD40L, T-B cell-activating molecule, T-cell antigen Gp39, TNF-related activation protein

Gene ID: 959

UniProt: P29965

Pathways: NF-kappaB Signaling, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints